Sarepta (SRPT) Pops Higher as Glaxo's DMD Drug Drisapersen Falters
Go back to Sarepta (SRPT) Pops Higher as Glaxo's DMD Drug Drisapersen Falters| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 50.82 +0.55 (1.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.27 | 52 Week High | $45.58 | |||
| Open | $50.22 | 52 Week Low | $37.82 | |||
| Day High | $50.88 | P/E | N/A | |||
| Day Low | $49.95 | EPS | $0.00 | |||
| Volume | 3,432,154 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 20.86 -0.73 (3.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.59 | 52 Week High | $63.73 | |||
| Open | $21.49 | 52 Week Low | $8.00 | |||
| Day High | $22.58 | P/E | N/A | |||
| Day Low | $20.83 | EPS | $-5.69 | |||
| Volume | 3,612,387 | |||||

